Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
Working Capital/Sales

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) 1.421.241.251.151.25

What is the latest Working Capital/Sales ratio of NATCO PHARMA ?

The latest Working Capital/Sales ratio of NATCO PHARMA is 1.42 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20241.42
Mar20231.24
Mar20221.25
Mar20211.15
Mar20201.25

How is Working Capital/Sales of NATCO PHARMA Trending?

Years Working Capital/Sales % Change
Mar2024 1.42
14.52
Mar2023 1.24
-0.80
Mar2022 1.25
8.70
Mar2021 1.15
-8.00
Mar2020 1.25 -

Other Financial Ratios of NATCO PHARMA


Compare Working Capital/Sales ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹23,464.8 Cr -5.6% -9.1% 66.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹443,145.0 Cr -2% 2.1% 42.6% Stock Analytics
DIVIS LABORATORIES ₹156,280.0 Cr -3.5% -3.4% 49.9% Stock Analytics
CIPLA ₹120,379.0 Cr -2.6% -0.6% 17.9% Stock Analytics
DR REDDYS LABORATORIES ₹112,701.0 Cr -2.7% 8.9% 14.2% Stock Analytics
ZYDUS LIFESCIENCES ₹96,774.5 Cr -1% -1.7% 36.9% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-5.6%

-9.1%

66.6%

SENSEX

-0.4%

-3.7%

7.9%


You may also like the below Video Courses